Jonathan Himmelfarb, MD
Professor of Medicine, Director - Kidney Research Institute, Department of Medicine, Division of Nephrology
The Kidney Research Institute was founded in 2008 as a joint venture between Northwest Kidney Centers and UW Medicine. Its purpose is to establish a leading clinical and translational research effort focusing on early detection, prevention and treatment of kidney disease and its complications. The Kidney Research Institute will provide a 360-degree examination of kidney disease with scientists in clinical medicine, pharmacology, genetics, pathology, psychology, education and physiology working closely with basic scientists in bioengineering, biochemistry, immunology, genomics and other disciplines.
- Conducting research that has high potential to tangibly improve the lives of those with kidney disease; for example, understanding uremia and other complications from loss of kidney function.
- Training pre- and post-doctoral fellows in a multidisciplinary and multicollaborative approach to clinically relevant questions.
- Collaborating and interacting within Northwest Kidney Centers and the Division of Nephrology, as well as with other Department of Medicine divisions, School of Medicine departments, and with the Schools of Public Health and Community Medicine, Education, Business, Engineering, Information Technology and Public Affairs. Dedicated clinical research space is available at Harborview Medical Center and at Northwest Kidney Centers.
Fighting an epidemic of kidney disease
- One in every seven adults in the United States has kidney disease--a 30 percent increase over the past decade. Prevalence rates around the world range between 10 and 13 percent.
- Twenty-four percent of the U.S. Medicare budget is spent treating kidney disease; 7 percent is spent on dialysis treatment.
- Chronic kidney disease is linked to premature cardiovascular disease, fractures, infections and diminished physical and mental functioning.
- Despite robust basic research, clinical practice has lagged in developing new treatment’s for kidney diseases, and in understanding uremic complications, and other important questions with direct impact on patients.